| Memantine for dementia R McShane, AA Sastre, N Minakaran Cochrane database of systematic reviews, 2006 | 1427 | 2006 |
| Donepezil and memantine for moderate-to-severe Alzheimer's disease R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... New England Journal of Medicine 366 (10), 893-903, 2012 | 906 | 2012 |
| The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial C Ballard, ML Hanney, M Theodoulou, S Douglas, R McShane, ... The Lancet Neurology 8 (2), 151-157, 2009 | 768 | 2009 |
| Memantine for dementia. SA Areosa, F Sherriff, R McShane The Cochrane database of systematic reviews, CD003154-CD003154, 2005 | 600* | 2005 |
| Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease M Rolinski, C Fox, I Maidment, R McShane Cochrane Database of Systematic Reviews, 2012 | 519 | 2012 |
| Tryptophan depletion in normal volunteers produces selective impairments in learning and memory SB Park, JT Coull, RH McShane, AH Young, BJ Sahakian, TW Robbins, ... Neuropharmacology 33 (3-4), 575-588, 1994 | 386 | 1994 |
| Lack of evidence for the efficacy of memantine in mild Alzheimer disease LS Schneider, KS Dagerman, JPT Higgins, R McShane Archives of neurology 68 (8), 991-998, 2011 | 378 | 2011 |
| Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up R McShane, J Keene, K Gedling, C Fairburn, R Jacoby, T Hope Bmj 314 (7076), 266, 1997 | 358 | 1997 |
| A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial) C Ballard, MM Lana, M Theodoulou, S Douglas, R McShane, R Jacoby, ... PLoS medicine 5 (4), e76, 2008 | 318 | 2008 |
| Ketamine and other glutamate receptor modulators for depression in adults C Caddy, BH Amit, TL McCloud, JM Rendell, TA Furukawa, R McShane, ... Cochrane Database of Systematic Reviews, 2015 | 220 | 2015 |
| Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression—TRANSFORM-3 R Ochs-Ross, EJ Daly, Y Zhang, R Lane, P Lim, RL Morrison, D Hough, ... The American Journal of Geriatric Psychiatry 28 (2), 121-141, 2020 | 218 | 2020 |
| Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease: A longitudinal study T Hope, J Keene, CG Fairburn, R Jacoby, R McShane The British Journal of Psychiatry 174 (1), 39-44, 1999 | 200 | 1999 |
| Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative AH Noel-Storr, JM McCleery, E Richard, CW Ritchie, L Flicker, SJ Cullum, ... Neurology 83 (4), 364-373, 2014 | 199 | 2014 |
| Getting lost in dementia: a longitudinal study of a behavioral symptom R McShane, K Gedling, J Keene, C Fairburn, R Jacoby, T Hope International Psychogeriatrics 10 (3), 253-260, 1998 | 198 | 1998 |
| Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic PR Diamond, AD Farmery, S Atkinson, J Haldar, N Williams, PJ Cowen, ... Journal of Psychopharmacology 28 (6), 536-544, 2014 | 197 | 2014 |
| 11C‐PIB‐PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) S Zhang, N Smailagic, C Hyde, AH Noel‐Storr, Y Takwoingi, R McShane, ... Cochrane Database of Systematic Reviews, 2014 | 190 | 2014 |
| Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... The Lancet Neurology 14 (12), 1171-1181, 2015 | 185 | 2015 |
| Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) C Ritchie, N Smailagic, AH Noel‐Storr, Y Takwoingi, L Flicker, SE Mason, ... Cochrane Database of Systematic Reviews, 2014 | 185 | 2014 |
| A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of … CG Ballard, A Thomas, J Fossey, L Lee, R Jacoby, MM Lana, C Bannister, ... Journal of Clinical Psychiatry 65 (1), 114-119, 2004 | 185 | 2004 |
| Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology RH McShane, Z Nagy, MM Esiri, E King, C Joachim, N Sullivan, AD Smith Journal of Neurology, Neurosurgery & Psychiatry 70 (6), 739-743, 2001 | 167 | 2001 |
